240 related articles for article (PubMed ID: 28285817)
1. Update on lysosomal acid lipase deficiency: Diagnosis, treatment and patient management.
Camarena C; Aldamiz-Echevarria LJ; Polo B; Barba Romero MA; García I; Cebolla JJ; Ros E
Med Clin (Barc); 2017 May; 148(9):429.e1-429.e10. PubMed ID: 28285817
[TBL] [Abstract][Full Text] [Related]
2. Deficiencia de lipasa ácida lisosomal, una patología infrecuente.
Gómez-Duarte C; García V; Botero V; Aristizabal A; Echeverri G; Pachajoa H
Gac Med Mex; 2019; 155(3):291-297. PubMed ID: 31219466
[TBL] [Abstract][Full Text] [Related]
3. Pediatric patients with lysosomal acid lipase deficiency.
Suarez-Zamora DA; Rojas-Rojas MM; Ordoñez-Guerrero F; Mugnier-Quijano J; Lopez-Panqueva R
Rev Esp Patol; 2023; 56(2):113-118. PubMed ID: 37061237
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies.
Vijay S; Brassier A; Ghosh A; Fecarotta S; Abel F; Marulkar S; Jones SA
Orphanet J Rare Dis; 2021 Jan; 16(1):13. PubMed ID: 33407676
[TBL] [Abstract][Full Text] [Related]
5. Lysosomal acid lipase deficiency: Expanding differential diagnosis.
Valayannopoulos V; Mengel E; Brassier A; Grabowski G
Mol Genet Metab; 2017; 120(1-2):62-66. PubMed ID: 27876313
[TBL] [Abstract][Full Text] [Related]
6. Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance.
Thelwall PE; Smith FE; Leavitt MC; Canty D; Hu W; Hollingsworth KG; Thoma C; Trenell MI; Taylor R; Rutkowski JV; Blamire AM; Quinn AG
J Hepatol; 2013 Sep; 59(3):543-9. PubMed ID: 23624251
[TBL] [Abstract][Full Text] [Related]
7. Mexican consensus on lysosomal acid lipase deficiency diagnosis.
Vázquez-Frias R; García-Ortiz JE; Valencia-Mayoral PF; Castro-Narro GE; Medina-Bravo PG; Santillán-Hernández Y; Flores-Calderón J; Mehta R; Arellano-Valdés CA; Carbajal-Rodríguez L; Navarrete-Martínez JI; Urbán-Reyes ML; Valadez-Reyes MT; Zárate-Mondragón F; Consuelo-Sánchez A
Rev Gastroenterol Mex (Engl Ed); 2018; 83(1):51-61. PubMed ID: 29287906
[TBL] [Abstract][Full Text] [Related]
8. Sebelipase alfa: enzymatic replacement treatment for lysosomal acid lipase deficiency.
Paton DM
Drugs Today (Barc); 2016 May; 52(5):287-93. PubMed ID: 27376161
[TBL] [Abstract][Full Text] [Related]
9. Lysosomal Acid Lipase Deficiency: Therapeutic Options.
Pastores GM; Hughes DA
Drug Des Devel Ther; 2020; 14():591-601. PubMed ID: 32103901
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome of a patient with lysosomal acid lipase deficiency and first results after initiation of treatment with Sebelipase alfa: A case report.
Soll D; Spira D; Hollstein T; Haberbosch L; Demuth I; Steinhagen-Thiessen E; Bobbert T; Spranger J; Kassner U
Mol Genet Metab Rep; 2019 Sep; 20():100479. PubMed ID: 31249784
[TBL] [Abstract][Full Text] [Related]
11. Lysosomal acid lipase deficiency allograft recurrence and liver failure- clinical outcomes of 18 liver transplantation patients.
Bernstein DL; Lobritto S; Iuga A; Remotti H; Schiano T; Fiel MI; Balwani M
Mol Genet Metab; 2018 May; 124(1):11-19. PubMed ID: 29655841
[TBL] [Abstract][Full Text] [Related]
12. Childhood/adult-onset lysosomal acid lipase deficiency: A serious metabolic and vascular phenotype beyond liver disease-four new pediatric cases.
Poinsot P; Collardeau Frachon S; Restier L; Sérusclat A; Di Filippo M; Charrière S; Moulin P; Lachaux A; Peretti N
J Clin Lipidol; 2017; 11(1):167-177.e3. PubMed ID: 28391883
[TBL] [Abstract][Full Text] [Related]
13. Sebelipase Alfa: A Review in Lysosomal Acid Lipase Deficiency.
Frampton JE
Am J Cardiovasc Drugs; 2016 Dec; 16(6):461-468. PubMed ID: 27878737
[TBL] [Abstract][Full Text] [Related]
14. Lysosomal Acid Lipase Deficiency in Japan: A Case Report of Siblings and a Literature Review of Cases in Japan.
Ikari N; Shimizu A; Asano T
J Nippon Med Sch; 2018; 85(2):131-137. PubMed ID: 29731497
[TBL] [Abstract][Full Text] [Related]
15. Safety of sebelipase alfa for the treatment of lysosomal acid lipase deficiency.
Ezgü F
Expert Opin Drug Saf; 2022 Feb; 21(2):149-155. PubMed ID: 34664536
[TBL] [Abstract][Full Text] [Related]
16. Sebelipase alfa: first global approval.
Shirley M
Drugs; 2015 Nov; 75(16):1935-40. PubMed ID: 26452566
[TBL] [Abstract][Full Text] [Related]
17. Enzyme replacement therapy in lysosomal acid lipase deficiency (LAL-D): a systematic literature review.
Bashir A; Tiwari P; Duseja A
Ther Adv Rare Dis; 2021; 2():26330040211026928. PubMed ID: 37181111
[TBL] [Abstract][Full Text] [Related]
18. Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study.
Jones SA; Rojas-Caro S; Quinn AG; Friedman M; Marulkar S; Ezgu F; Zaki O; Gargus JJ; Hughes J; Plantaz D; Vara R; Eckert S; Arnoux JB; Brassier A; Le Quan Sang KH; Valayannopoulos V
Orphanet J Rare Dis; 2017 Feb; 12(1):25. PubMed ID: 28179030
[TBL] [Abstract][Full Text] [Related]
19. The role of sebelipase alfa in the treatment of lysosomal acid lipase deficiency.
Erwin AL
Therap Adv Gastroenterol; 2017 Jul; 10(7):553-562. PubMed ID: 28804516
[TBL] [Abstract][Full Text] [Related]
20. Identification of rare diseases by screening a population selected on the basis of routine pathology results-the PATHFINDER project: lysosomal acid lipase/cholesteryl ester storage disease substudy.
Reynolds TM; Mewies C; Hamilton J; Wierzbicki AS;
J Clin Pathol; 2018 Jul; 71(7):608-613. PubMed ID: 29358478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
